Utah Medical Products EBITDA Margin 2010-2025 | UTMD

Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Utah Medical Products (UTMD) over the last 10 years. The current EBITDA margin for Utah Medical Products as of March 31, 2025 is .
Utah Medical Products EBITDA Margin Historical Data
Date TTM Revenue TTM EBITDA EBITDA Margin
2025-03-31 $0.04B $0.02B 41.03%
2024-12-31 $0.04B $0.02B 42.50%
2024-09-30 $0.04B $0.02B 41.86%
2024-06-30 $0.05B $0.02B 43.48%
2024-03-31 $0.05B $0.02B 44.90%
2023-12-31 $0.05B $0.02B 45.10%
2023-09-30 $0.05B $0.03B 47.17%
2023-06-30 $0.05B $0.03B 49.06%
2023-03-31 $0.05B $0.03B 50.94%
2022-12-31 $0.05B $0.03B 51.92%
2022-09-30 $0.05B $0.03B 52.94%
2022-06-30 $0.05B $0.03B 52.94%
2022-03-31 $0.05B $0.03B 52.94%
2021-12-31 $0.05B $0.03B 54.00%
2021-09-30 $0.05B $0.03B 53.06%
2021-06-30 $0.05B $0.02B 52.17%
2021-03-31 $0.04B $0.02B 50.00%
2020-12-31 $0.04B $0.02B 50.00%
2020-09-30 $0.04B $0.02B 50.00%
2020-06-30 $0.04B $0.02B 50.00%
2020-03-31 $0.05B $0.02B 51.06%
2019-12-31 $0.05B $0.02B 51.06%
2019-09-30 $0.05B $0.02B 51.11%
2019-06-30 $0.04B $0.02B 51.16%
2019-03-31 $0.04B $0.02B 52.38%
2018-12-31 $0.04B $0.02B 52.38%
2018-09-30 $0.04B $0.02B 52.38%
2018-06-30 $0.04B $0.02B 52.38%
2018-03-31 $0.04B $0.02B 52.38%
2017-12-31 $0.04B $0.02B 51.22%
2017-09-30 $0.04B $0.02B 50.00%
2017-06-30 $0.04B $0.02B 50.00%
2017-03-31 $0.04B $0.02B 48.72%
2016-12-31 $0.04B $0.02B 48.72%
2016-09-30 $0.04B $0.02B 50.00%
2016-06-30 $0.04B $0.02B 50.00%
2016-03-31 $0.04B $0.02B 50.00%
2015-12-31 $0.04B $0.02B 50.00%
2015-09-30 $0.04B $0.02B 50.00%
2015-06-30 $0.04B $0.02B 48.78%
2015-03-31 $0.04B $0.02B 48.78%
2014-12-31 $0.04B $0.02B 48.78%
2014-09-30 $0.04B $0.02B 46.34%
2014-06-30 $0.04B $0.02B 45.00%
2014-03-31 $0.04B $0.02B 45.00%
2013-12-31 $0.04B $0.02B 45.00%
2013-09-30 $0.04B $0.02B 45.00%
2013-06-30 $0.04B $0.02B 47.50%
2013-03-31 $0.04B $0.02B 45.00%
2012-12-31 $0.04B $0.02B 43.90%
2012-09-30 $0.04B $0.02B 43.90%
2012-06-30 $0.04B $0.02B 40.48%
2012-03-31 $0.04B $0.02B 40.48%
2011-12-31 $0.04B $0.01B 36.84%
2011-09-30 $0.03B $0.01B 35.29%
2011-06-30 $0.03B $0.01B 34.48%
2011-03-31 $0.03B $0.01B 32.00%
2010-12-31 $0.02B $0.01B 33.33%
2010-09-30 $0.02B $0.01B 37.50%
2010-06-30 $0.03B $0.01B 40.00%
2010-03-31 $0.03B $0.01B 40.00%
2009-12-31 $0.03B $0.01B 44.00%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.188B $0.041B
Utah Medical Products is in the business of producing cost-effective devices for the healthcare industry which are predominantly proprietary, disposable and for hospital use. The company's success in rapidly producing solutions comes from its proven ability to integrate a number of engineering and technical disciplines in electronics, software, mechanical packaging, instrumentation, optics and materials. The resulting proprietary products represent significant incremental improvementsover existing clinical techniques.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $233.799B 28.11
Boston Scientific (BSX) United States $157.605B 39.46
Stryker (SYK) United States $150.214B 31.41
EssilorLuxottica (ESLOY) France $126.765B 0.00
Medtronic (MDT) Ireland $110.324B 15.64
Lonza Group Ag (LZAGY) Switzerland $50.804B 0.00
Haleon (HLN) United Kingdom $46.650B 26.61
ResMed (RMD) United States $37.413B 28.10
GE HealthCare Technologies (GEHC) United States $34.057B 16.17
Agilent Technologies (A) United States $33.852B 22.07
Terumo (TRUMY) Japan $27.835B 36.15
Koninklijke Philips (PHG) Netherlands $23.245B 16.31
Insulet (PODD) United States $22.033B 86.49
Zimmer Biomet Holdings (ZBH) United States $18.095B 11.62
Baxter (BAX) United States $15.595B 11.64
Smith & Nephew SNATS (SNN) United Kingdom $13.236B 0.00
Demant (WILYY) Denmark $9.110B 0.00
Sunny Optical Technology (SNPTF) China $8.561B 0.00
Bio-Rad Laboratories (BIO) United States $6.639B 23.10
Lantheus Holdings (LNTH) United States $5.638B 14.22
Prestige Consumer Healthcare (PBH) United States $3.998B 17.86
Perrigo (PRGO) Ireland $3.649B 9.25
Haemonetics (HAE) United States $3.545B 16.15
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Envista Holdings (NVST) United States $3.334B 27.70
ICU Medical (ICUI) United States $3.244B 23.92
GN Store Nord (GNNDY) Denmark $2.307B 19.11
QuidelOrtho (QDEL) United States $1.952B 13.43
LeMaitre Vascular (LMAT) United States $1.866B 41.70
AtriCure (ATRC) United States $1.598B 0.00
AdaptHealth (AHCO) United States $1.289B 13.08
Acuren (TIC) United States $1.271B 0.00
Green Thumb Industries (GTBIF) United States $1.111B 25.00
Phibro Animal Health (PAHC) United States $1.040B 13.30
Neogen (NEOG) United States $1.027B 13.14
BioLife Solutions (BLFS) United States $1.021B 0.00
Kestra Medical Technologies (KMTS) United States $0.907B 0.00
InMode (INMD) Israel $0.897B 9.04
Owens & Minor (OMI) United States $0.685B 5.69
CeriBell (CBLL) United States $0.683B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.629B 0.00
Evolus (EOLS) United States $0.589B 0.00
Curaleaf Holdings (CURLF) Canada $0.531B 0.00
Capricor Therapeutics (CAPR) United States $0.509B 0.00
Valneva SE (VALN) France $0.494B 0.00
Surmodics (SRDX) United States $0.412B 0.00
Tilray Brands (TLRY) Canada $0.403B 0.00
VAREX IMAGING (VREX) United States $0.354B 13.00
Quanterix (QTRX) United States $0.332B 0.00
SNDL (SNDL) Canada $0.323B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.301B 0.00
Viemed Healthcare (VMD) United States $0.274B 23.07
Cerus (CERS) United States $0.271B 0.00
ZimVie (ZIMV) United States $0.258B 11.72
Sanuwave Health (SNWV) United States $0.256B 0.00
Sanara MedTech (SMTI) United States $0.253B 0.00
Brainsway (BWAY) Israel $0.250B 66.10
Cresco Labs (CRLBF) United States $0.246B 0.00
Aurora Cannabis (ACB) Canada $0.233B 69.17
Biote (BTMD) United States $0.230B 6.46
OraSure Technologies (OSUR) United States $0.225B 0.00
Canopy Growth (CGC) Canada $0.224B 0.00
TriSalus Life Sciences (TLSI) United States $0.201B 0.00
Omeros (OMER) United States $0.188B 0.00
High Tide (HITI) Canada $0.184B 0.00
Organigram Global (OGI) Canada $0.181B 0.00
Verano Holdings (VRNOF) United States $0.177B 0.00
Exagen (XGN) United States $0.149B 0.00
Vireo Growth (VREOF) United States $0.144B 0.00
FitLife Brands (FTLF) United States $0.120B 0.00
Jin Medical (ZJYL) China $0.102B 0.00
Fonar (FONR) United States $0.092B 11.90
Oramed Pharmaceuticals (ORMP) United States $0.088B 0.00
Veru (VERU) United States $0.085B 0.00
Apyx Medical (APYX) United States $0.082B 0.00
Quipt Home Medical (QIPT) United States $0.078B 0.00
Zynex (ZYXI) United States $0.077B 0.00
Cytosorbents (CTSO) United States $0.077B 0.00
TerrAscend (TSNDF) Canada $0.077B 0.00
MacroGenics (MGNX) United States $0.075B 0.00
InterCure (INCR) Israel $0.068B 0.00
Agape ATP (ATPC) $0.066B 0.00
ImmuCell (ICCC) United States $0.061B 0.00
Jushi Holdings (JUSHF) United States $0.057B 0.00
Nephros (NEPH) United States $0.041B 55.14
United-Guardian (UG) United States $0.037B 12.94
Modular Medical (MODD) United States $0.037B 0.00
Rockwell Medical (RMTI) United States $0.027B 0.00
Safety Shot (SHOT) United States $0.023B 0.00
Allurion Technologies (ALUR) United States $0.018B 0.00
INLIF (INLF) $0.016B 0.00
Meihua Medical Technologies (MHUA) China $0.014B 0.00
Cellectar Biosciences (CLRB) United States $0.014B 0.00
Flora Growth (FLGC) United States $0.014B 0.00
Trinity Biotech (TRIB) Ireland $0.012B 0.00
Senestech (SNES) United States $0.010B 0.00
Innovative Eyewear (LUCY) United States $0.006B 0.00
IM Cannabis (IMCC) Canada $0.006B 0.00
GlucoTrack (GCTK) United States $0.003B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00